Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials

por Ang, Joo Ern, Kaye, Stan, Banerji, Udai
Publicado 2012

Identification of Human Plasma Metabolites Exhibiting Time-of-Day Variation Using an Untargeted Liquid Chromatography–Mass Spectrometry Metabolomic Approach

por Ang, Joo Ern, Revell, Victoria, Anuska, Mann, Mäntele, Simone, Otway, Daniella T., Johnston, Jonathan D., Thumser, Alfred E., Skene, Debra J., Raynaud, Florence
Publicado 2012

A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors

por Spicer, James, Irshad, Sheeba, Ang, Joo Ern, Enting, Deborah, Kristeleit, Rebecca, Uttenreuther-Fischer, Martina, Pemberton, Karine, Pelling, Katy, Schnell, David, de Bono, Johann
Publicado 2016

A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials

por Ingles Garces, Alvaro H., Ang, Joo Ern, Ameratunga, Malaka, Chénard-Poirier, Maxime, Dolling, David, Diamantis, Nikolaos, Seeramreddi, Satyanarayana, Sundar, Raghav, de Bono, Johann, Lopez, Juanita, Banerji, Udai
Publicado 2018

Investigation of metabolites for estimating blood deposition time

por Lech, Karolina, Liu, Fan, Davies, Sarah K., Ackermann, Katrin, Ang, Joo Ern, Middleton, Benita, Revell, Victoria L., Raynaud, Florence J., Hoveijn, Igor, Hut, Roelof A., Skene, Debra J., Kayser, Manfred
Publicado 2017

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study

por Sahin, Hilal, Panico, Camilla, Ursprung, Stephan, Simeon, Vittorio, Chiodini, Paolo, Frary, Amy, Carmo, Bruno, Smith, Janette, Freeman, Sue, Jimenez-Linan, Mercedes, Bolton, Helen, Haldar, Krishnayan, Ang, Joo Ern, Reinhold, Caroline, Sala, Evis, Addley, Helen
Publicado 2021

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

por Rafii, Saeed, Gourley, Charlie, Kumar, Rajiv, Geuna, Elena, Ang, Joo Ern, Rye, Tzyvia, Chen, Lee-May, Shapira-Frommer, Ronnie, Friedlander, Michael, Matulonis, Ursula, Greve, Jacques De, Oza, Amit M., Banerjee, Susana, Rhoda Molife, L., Gore, Martin E., Kaye, Stan B., Yap, Timothy A.
Publicado 2017

Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab

por Minchom, Anna, Yuan, Wei, Crespo, Mateus, Gurel, Bora, Figueiredo, Ines, Wotherspoon, Andrew, Miranda, Susana, Riisnaes, Ruth, Ferreira, Ana, Bertan, Claudia, Pereira, Rita, Clarke, Matt, Baker, Chloe, Ang, Joo Ern, Fotiadis, Nicos, Tunariu, Nina, Carreira, Suzanne, Popat, Sanjay, O'Brien, Mary, Banerji, Udai, de Bono, Johann, Lopez, Juanita
Publicado 2020

Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer

por Beer, Lucian, Martin-Gonzalez, Paula, Delgado-Ortet, Maria, Reinius, Marika, Rundo, Leonardo, Woitek, Ramona, Ursprung, Stephan, Escudero, Lorena, Sahin, Hilal, Funingana, Ionut-Gabriel, Ang, Joo-Ern, Jimenez-Linan, Mercedes, Lawton, Tristan, Phadke, Gaurav, Davey, Sally, Nguyen, Nghia Q., Markowetz, Florian, Brenton, James D., Crispin-Ortuzar, Mireia, Addley, Helen, Sala, Evis
Publicado 2020

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous...

por Banerjee, Susana, Michalarea, Vasiliki, Ang, Joo Ern, Ingles Garces, Alvaro, Biondo, Andrea, Funingana, Ionut-Gabriel, Little, Martin, Ruddle, Ruth, Raynaud, Florence, Riisnaes, Ruth, Gurel, Bora, Chua, Sue, Tunariu, Nina, Porter, Joanna C., Prout, Toby, Parmar, Mona, Zachariou, Anna, Turner, Alison, Jenkins, Ben, McIntosh, Stuart, Ainscow, Ed, Minchom, Anna, Lopez, Juanita, de Bono, Johann, Jones, Robert, Hall, Emma, Cook, Natalie, Basu, Bristi, Banerji, Udai
Publicado 2022